Joshua Silverman, CEO and President at PharmaCyte Biotech, Inc. (PMCB), bought 100,000 shares at $0.79 ($80K) on 2026-01-06, disclosed to the SEC on 2026-01-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.78 | 30,000 | $23K | 29.1% |
| 2 | $0.79 | 30,000 | $24K | 29.5% |
| 3 | $0.83 | 40,000 | $33K | 41.3% |
| Total | $0.80 avg | 100,000 | $80K | 100% |
| Filing → |
| AYRO | SELL | 2023-02-03 | $5K | — | Filing → |
| SNPX | SELL | 2022-12-20 | $22K | — | Filing → |
| AYRO | SELL | 2022-11-03 | $15K | — | Filing → |